Migraine associated with patent foramen ovale may be caused by reactivation of cerebral toxoplasmosis triggered by arterial blood oxygen desaturation

International Journal of Neuroscience

Volumn 120, Issue 2, 2010, Pages 81-87

  Prandota, Joseph ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cerebral toxoplasmosis; Hypoxia; Immune imbalance; Migraine; Paradoxical microembolism; Patent foramen ovale; Stroke

Indexed keywords

CHEMOKINE RECEPTOR; CYCLOOXYGENASE 2; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL OXYGEN SATURATION; ARTICLE; B LYMPHOCYTE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; DISEASE ASSOCIATION; FIBRINOLYSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HUMAN; HYPERCOAGULABILITY; HYPOXIA; IMMUNOGLOBULIN PRODUCTION; MICROEMBOLISM; MIGRAINE; PATENT FORAMEN OVALE; PROTEIN EXPRESSION; T LYMPHOCYTE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

FORAMEN OVALE, PATENT; GENE EXPRESSION; HUMANS; HYPOXIA, BRAIN; MIGRAINE DISORDERS; MIGRAINE WITH AURA; OXYGEN; RECURRENCE; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CEREBRAL; TOXOPLASMOSIS, CONGENITAL;

EID: 77749239694     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207450903458647     Document Type: Article

References (98)

1. Agarwal, S. K., & Marshall, G. D. Jr. (2001). Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. Journal of Interferon and Cytokine Research, 21, 147-155.
2. Al-Bahrani, A., Taha, S., Shaath, H., & Bakhiet, M. (2007). TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Current Neurovascular Research, 4, 31-37.
3. Alfonso, Y., Fraga, J., Cox, R., Bandera, F., Pomier, O., Fonseca, C., et al. (2008). Comparison of four DNA extraction methods from cerebrospinal fluid for the detection of Toxoplasma gondii by polymerase chain reaction in AIDS patients. Medical Science Monitoring, 14, MT1-MT6.
4. Alfonso, Y., Fraga, J., Jimenez, N., Fonseca, C., Dorta-Contreras, A. J., Cox, R., et al. (2009). Detection of Toxoplasma gondii in cerebrospinal fluid from AIDS patients by nested PCR and rapid identification of type I allele at B1 gene by RFLP analysis. Experimental Parasitology, 122(3), 203-207.
5. Aliberti, J. (2005). Host persistence: Exploitation of antiinflammatory pathways by Toxoplasma gondii. Nature Reviews Immunology, 5, 162-170.
6. Anzola, G. P., Frisoni, G. B., Morandi, E., Casilli, F., & Onorato, E. (2006). Shunt-associated migraine responds favorably to atrial septal repair: A case-control study. Stroke, 37, 430-434.
7. Beaman, M. H., McCabe, R. E., Wong, S. Y., & Remington, J. S. (1995). Toxoplasma gondii. In G. L. Mandell, J.E. Bennet, and R. Dolin (eds.), Principles and Practices of Infectious Diseases, 4th ed. New York, NY: Churchill Livingstone, 2455-2475.
8. Beghetto, E., Spadoni, A., Bruno, L., Buffolano, W., & Gargano, N. (2006). Chimeric antigens of Toxoplasma gondii: Toward standardization of toxoplasmosis serodiagnosis using recombinant products. Journal of Clinical Microbiology, 44, 2133-2140.
9. Benseñor, I. M., Cook, N. R., Lee, I. M., Chown, M. J., Hennekens, C. H., & Buring, J. E. (2001). Low-dose aspirin for migraine prophylaxis in women. Cephalalgia, 21, 175-183.
10. Bhopale, G. M. (2003). Pathogenesis of toxoplasmosis. Comparative Immunology Microbiology and Infectious Diseases, 26, 213-222.
11. Bø, S. H., Davidsen, E. M., Gulbrandsen, P., Dietrichs, E., Bovim, G., Stovner, L. J., et al. (2008). Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia, 29, 365-372.
12. Borges, A. S., & Figueiredo, J. F. (2004). Detection of anti-Toxoplasma gondii IgG, IgM and IgA immunoglobulins in the serum, cerebrospinal fluid and saliva of patients with acquired immunodeficiency syndrome and neurotoxoplasmosis. Arquivos de neuro-psiquiatria, 62, 1033-1037.
13. Botcher, B. A., Kim, L., Johnson, P. F., & Denkers, E. Y. (2001). Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. Journal of Immunology, 167, 2193-2201.
14. Bou, G., Figueroa, M. S., Marti-Belda, P., Navas, E., & Guerrero, A. (1999). Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. Journal of Clinical Microbiology, 37, 3465-3468.
15. Bousser, M. G. (2007). Patent foramen ovale and migraine. Revue Neurologique (Paris), 163, 17-25.
16. Buring, J. E., Peto, R., & Hennekens, C. H. (1990). Low-dose aspirin for migraine prophylaxis. Journal of American Medical Association, 264, 1711-1713.
17. Calderaro, A., Peruzzi, S., Piccolo, G., Gorrini, C., Montecchini, S., Rossi, S., et al. (2009). Laboratory diagnosis of Toxoplasma gondii infection. International Journal of Medical Sciences, 6, 135-136.
18. Cesar, J. M., Garcia-Avello, A., Vecino, A. M., Sastre, J. L., & Alvarez-Cemeno, J. C. (1995). Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurologica Scandinavica, 91, 412-413.
19. Clanton, T. L. (2007). Hypoxia-induced reactive oxygen species formation in skeletal muscle. Journal of Applied Physiology, 102, 2379-2388.
20. Dalla Volta, G., Guindani, M., Zavarise, P., Griffini, S., Pezzini, A., & Padovani, A. (2005). Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. Journal of Headache Pain, 6, 328-330.
21. Dubey, J. P. (1998). Advances in the life cycle of Toxoplasma gondii. International Journal of Parasitology, 28, 1019-1024.
22. Dubey, J. P., & Beattie, C. P. (1988). Toxoplasmosis in Animals and Man. Boca Raton, FL: CRC Press, 1-220.
23. Dunzendorfer, S., Reinisch, C. M., Kaneider, N. C., Pechlaner, Ch., & Wiedermann, Ch. J. (2002). Inhibition of plasma-dependent monocyte chemokinesis and cytokine-triggered endothelial activation for neutrophil transmigration by administration of clopidogrel in man. Acta Medica Austriaca, 29, 100-106.
24. Gazzinelli, R. T., Eltoum, I., Wynn, T. A., & Sher, A. (1993). Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. Journal of Immunology, 151, 3672-3681.
25. Gergont, A., & Kacinski, M. (2005). Blood interleukin-6 level in children with idiopathic headache. Neurologia i Neurochirurgia Polska, 39(4 Suppl 1), S1-S8.
26. Gergont, A., Kacinski, M., & Kwinta, P. (2005). Proinflammatory cytokines in children with idiopathic headache. Przeglad Lekarski, 62, 1269-1275.
27. Goadsby, P. J. (2005). Is migraine a progressive disorder? Medical Journal of Australia, 182, 103-104.
28. Godart, F., Rey, C., Prat, A., Vincentelli, A., Chmait, A., Francart, C., et al. (2000). Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. European Heart Journal, 21, 483-489.
29. Gori, A. M., Cesari, F., Marcucci, R., Giusti, B., Paniccia, R., Antonucci, E., et al. (2009). The balance between pro-and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Atherosclerosis, 202, 255-262.
30. Haddad, J. J., & Harb, H. L. (2005). Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. International Immunopharmacology, 5, 461-483.
31. Hagen, P. T., Scholtz, D. G., & Edwards, W. D. (1984). Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clinic Proceedings, 59, 17-20.
32. Hansen, R. A., Gartlehner, G., Powell, G. E., & Sandler, R. S. (2007). Serious adverse events with infliximab: Analysis of spontaneously reported adverse events. Clinical Gastroenterology and Hepatology, 5, 729-735.
33. Hill-Kapturczak, N., Truong, L., Thamilselvan, V., Visner, G. A., Nick, H. S., & Agarwal, A. (2000). Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-beta in human renal epithelial cells. Journal of Biology and Chemistry, 275, 40904-40909.
34. Ishizaki, K., Takeshima, T., Fukuhara, Y., Araki, H., Nakaso, K., Kusumi, M., et al. (2005). Increased plasma transforming growth factor-beta 1 in migraine. Headache, 45, 1224-1228.
35. Israelski, D. M., & Remington, J. S. (1993). Toxoplasmosis in non-AIDS immunocompromised host. Current Opinion in Tropical Infectious Diseases, 13, 322-356.
36. Ji, Y. S., Xu, Q., & Schmedtje, J. F., Jr. (1998). Hypoxia induces high-mobility-group protein I (Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium. Circulation Research, 83, 295-304.
37. Kacinski, M., Gergont, A., Kubik, A., & Steczkowska-Klucznik, M. (2005). Proinflammatory cytokines in children with migraine with or without aura. Przeglad Lekarski, 62, 1276-1280.
38. Kang, K.-M., Choi, I.-U., Shin, D.-W. & Lee, Y.-H. (2006). Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamethasone. Korean Journal of Parasitology, 44, 209-219.
39. Koseoglu, E., Yazar, S., & Koc, I. (2009). Is Toxoplasma gondii a causal agent in migraine? American Journal of Medical Sciences, 338(2), 120-122 [Epub ahead of print].
40. Lam, S. Y., Tipoe, G. L., Liong, E. C., & Fung, M. L. (2008). Chronic hypoxia upregulates the expression and function of proinflammatory cytokines in the rat carotid body. Histochemistry and Cell Biology, 130, 549-559.
41. Lassoued, S., Zabraniecki, L., Marin, F., & Billey, T. (2007). Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 36, 262-263.
42. Li, M., Zhang, Y., Ren, H., Zhang, Y., & Zhu, X. (2006). Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis, 194, 348-356.
43. Madajka, M., Korda, M., White, J., & Malinski, T. (2003). Effect of aspirin on constitutive nitric oxide synthase and the bioavailability of NO. Thrombosis Research, 110, 317-321.
44. Meier, B. (2009). Stroke and migraine: A cardiologist's headache. Heart, 95, 595-602.
45. Min, K.-J., Yang, M., Kim, S.-U., Jou, I., & Joe, E. (2006). Astrocytes induce hemeoxygenase-1 expression in microglia: A feasible mechanism for preventing excessive brain inflammation. Journal of Neuroscience, 26, 1880-1887.
46. Nishio, E., & Watanabe, Y. (1998). Aspirin and salicylate enhances the induction of inducible nitric oxide synthase in cultured rat smooth muscle cells. Life Sciences, 63, 429-439.
47. Nowakowska, D., Colon, I., Remington, J. S., Grigg, M., Golab, E., Wilczynski, J., et al. (2006). Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. Journal of Clinical Microbiology, 44, 1382-1389.
48. O'Kane, P. D., Reebye, V., Ji, Y., Stratton, P., Jackson, G., & Ferro, A. (2008). Aspirin and clopidogrel treatment impair nitric oxide biosynthesis. Journal of Molecular and Cellular Cardiology, 45, 223-229.
49. Ozaki, Y., Edelstein, M. P., & Duch, D. S. (1987). The actions of interferon and anti-inflammatory agents on induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochemical and Biophysical Research Communications, 144, 1147-1153.
50. Peng, B. W., Lin, J., Lin, J. Y., Jiang, M. S., & Zhang, T. (2003). Exogenous nitric oxide induces apoptosis in Toxoplasma gondii tachyzoites via a calcium signal transduction pathway. Parasitology, 126, 541-550.
51. Piergili Fioretti, D. (2004). Problems and limitations of conventional and innovative methods for the diagnosis of toxoplasmosis in humans and animals. Parassitologia, 46, 177-181.
52. Pinsky, D. J., Liao, H., Lawson, C. A., Yan, S. F., Chen, J., Carmeliet, P., et al. (1998). Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. Journal of Clinical Investigation, 102, 919-928.
53. Prandota, J. (1998). Persisting headache as an early symptom of acquired toxoplasmosis not manifested with the enlargement of the peripheral lymphatic nodes. Further cases. Klinika, 5, 930-934.
54. Prandota, J. (2004). Possible pathomechanisms of sudden infant death syndrome. Key role of chronic hypoxia, infection/inflammation states, cytokine irregularities, and metabolic trauma in genetically predisposed infants. American Journal of Therapeutics, 11, 517-546.
55. Prandota, J. (2007). Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in non-human immunodeficiency virus-infected subjects with no lymphadenopathy. The parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. American Journal of Therapeutics, 14, 63-105.
56. Prandota, J. (2008). Headaches and aseptic meningitis (AM) may be clinical manifestations of the Jarisch-Herxheimer reaction. Archives of Disease in Childhood, 93, 42, 43 (Abstract).
57. Prandota, J. (2009a). Mollaret meningitis may be caused by reactivation of latent cerebral toxoplasmosis. International Journal of Neuroscience, 119, 1655-1692.
58. Prandota, J. (2009b). The importance of Toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction. International Journal of Neuroscience, 119, 2144-2182.
59. Prandota, J. (in press). Idiopathic intracranial hypertension may be caused by reactivation of latent cerebral toxoplasmosis. Effect of various diseases and clinical states. International Journal of Neuroscience.
60. Prandota, J. (in press). Idiopathic intracranial hypertension may be caused by reactivation of latent cerebral toxoplasmosis probably because of disturbances in the host and/or Toxoplasma gondii immune defense mechanisms. Effect of various medications and biologic agents. Recent Patents on CNS Drug Discovery.
61. Prandota, J., Panków-Prandota, L., & Kotecki, L. (2001a). Impaired activation of the fibrinolytic system in children with Henoch-Schönlein purpura: Beneficial effect of hydrocortisone plus ε-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. American Journal of Therapeutics, 8, 11-19.
62. Prandota, J., Panków-Prandota, L., Kotecki, L., & Noga, L. (2001b). Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus ε-aminocaproic acid treatment regimens: A preliminary report. American Journal of Therapeutics, 8, 97-107.
63. Prandota, J., Sikorska, E., Woloszczuk, B., & Dzik, E. (1988). Persisting headache as an early symptom of acquired toxoplasmosis not manifested by enlargement of peripheral lymphatic nodes. Pediatria Polska, 63, 483-489.
64. Quinn, M. J., Bhatt, D. L., Zidar, F., Vivekananthan, D., Chew, D. P., Ellis, S. G., et al. (2004). Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. The American Journal of Cardiology, 93, 679-684.
65. Rasmussen, B. K. (2001). Epidemiology of headache. Cephalalgia, 21, 774-777.
66. Reisman, M., Christofferson, R. D., Jesurum, J., Olsen, J. V., Spencer, M. P., Krabill, K. A., et al. (2005). Migraine headache relief after transcatheter closure of patent foramen ovale. Journal of American College of Cardiology, 45, 493-495.
67. Remington, J. S., Thuillez, P., & Montoya, J. G. (2004). Recent developments for diagnosis of toxoplasmosis. Journal of Clinical Microbiology, 42, 941-945.
68. Rigatelli, G., Braggion, G., Aggio, S., Chinaglia, M., & Cardaioli, P. (2006). Primary patent foramen ovale closure to relieve severe migraine. Archives of Internal Medicine, 144, 458-460.
69. Rodriguez, C. J., Homma, S., Sacco, R. L., Di Tullio, M. R., Sciacca, R. R., Mohr, J. P., et al. (2003). Race-ethnic differences in patent foramen ovale, atrial septal aneurysm, and right atrial anatomy among ischemic stroke patients. Stroke, 34, 2097-2102.
70. Sarchielli, P., Alberti, A., Baldi, A., Coppola, F., Rossi, C., Pierguidi, L., et al. (2006). Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache, 46, 200-207.
71. Sayama, S., Yoshida, R., Oku, T., Imanishi, J., Kishida, T., & Hayaishi, O. (1981). Inhibition of interferon-mediated induction of indoleamine 2,3-dioxygenase in mouse lung by inhibitors of prostaglandin biosynthesis. Proceedings of the National Academy of Sciences USA, 78, 7327-7330.
72. Scannel, G. (1996). Leukocyte responses to hypoxic/ischemia conditions. New Horizons, 4, 179-183.
73. Schroecksnadel, K., Frick, B., Winkler, C., Leblhuber, F., Wirleitner, B., & Fuchs, D. (2005a). Aspirin downregulates homocysteine formation in stimulated human peripheral mononuclear cells. Scandinavian Journal of Immunology, 62, 155-160.
74. Schroecksnadel, K., Frick, B., Winkler, C., Wirleitner, B., Schennah, H., & Fuchs, D. (2003). Hyperhomocysteinemia and immune activation. Clinical Chemistry and Laboratory Medicine, 62, 155-160.
75. Schroecksnadel, K., Winkler, C., Wirleitner, B., Schennah, H., & Fuchs, D. (2005b). Aspirin down-regulates tryptophan degradation in stimulated human peripheral mononuclear cells in vitro. Clinical and Experimental Immunology, 140, 41-45.
76. Schuchlenz, H. W., Weihs, W., Horner, S., & Quehenberger, F. (2000). The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. American Journal of Medicine, 109, 456-462.
77. Schwerzmann, M., Nedeltchev, K., Lagger, F., Mattle, H. P., Windecker, S., Meier, B., et al. (2005). Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology, 65, 1415-1418.
78. Schwerzmann, M., Wiher, S., Nedeltchev, K., Mattle, H. P., Wahl, A., Seiler, C., et al. (2004). Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology, 62, 1399-1401.
79. Shanoudy, H., Soliman, A., Raggi, P., Liu, J. W., Russell, D. C., & Jarmukli, N. F. (1998). Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest, 113, 91-96.
80. Shimpo, M., Ikeda, U., Maeda, Y., Ohya, K., Murakami, Y., & Shimada K. (2000). Effects of aspirin-like drugs on nitric oxide synthesis in rat vascular smooth muscle cells. Hypertension, 35, 1085-1091.
81. Spear, W., Chan, D., Coppens, I., Johnson, R. S., Giaccia, A., & Blader, U. (2006). The host cell transcription factor hypoxiainducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiology, 8, 339-352.
82. Stanimirovic, D., Zhang, W., Howlett, C., Lemieux, P., & Smith, C. (2001). Inflammatory gene transcription in human astrocytes exposed to hypoxia: Roles of the nuclear factor-kappaB and autocrine stimulation. Journal of Neuroimmunology, 119, 365-376.
83. Suzuki, Y. (2002). Immunopathogenesis of cerebral toxoplasmosis. Journal of Infectious Diseases, 186(Suppl 2), S234-S240.
84. Switaj, K., Master, A., Skrzypczak, M., & Zaborowski, P. (2005). Recent trends in molecular diagnostics for Toxoplasma gondii infections. Clinical Microbiology and Infection, 11, 170-176.
85. Sztajzel, R., Genoud, D., Roth, S., Mermillod, B., & Le Floch-Rohr, J. (2002). Patent foramen ovale, a possible cause of symptomatic migraine: A study of 74 patients with acute ischemic stroke. Cerebrovascular Diseases, 13, 102-106.
86. Tietjen, G. E., Al-Qasmi, M. M., Athanas, K., Dafer, R. M., & Khuder, S. A. (2001). Increased von Willebrand factor in migraine. Neurology, 57, 334-336.
87. Tietjen, G. E., Al.-Qasmi, M. M., Athanas, K., Utley, C., & Herial, N. A. (2007). Altered hemostasis in migraineurs studied with a dynamic flow system. Thrombosis Research, 119, 217-222.
88. Upton, R. B., & Bigal, M. E. (2005). The epidemiology of migraine. American Journal of Medicine, 118(Suppl 1), S3-S10.
89. Vigna, C., Marchese, N., Inchingolo, V., Giannatempo, G. M., Pacilli, M. A., Di Viesti, P., et al. (2009). Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions. Journal of American College of Cardiologic Intervention, 2, 107-113.
90. Wenger, R. H., Rolfs, A., Marti, H. H., Bauer, C., & Gassmann, M. (1995). Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. Journal of Biological Chemistry, 270, 27865-27870.
91. Willis, D., Moore, A. R., Frederick, R., & Willoughby, D. A. (1996). Heme oxygenase: A novel target for the modulation of the inflammatory response. Natural Medicine, 2, 87-90.
92. Wilmshurst, P. T., Byrne, J. C., & Webb-Peploe, M. M. (1989). Relation between interatrial shunts and decompression sickness in divers. Lancet, 2, 1302-1306.
93. Wilmshurst, P. T., & Nightingale, S. (2001). Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clinical Science (London), 100, 215-220.
94. Wilmshurst, P. T., Nightingale, S., Walsh, K. P., & Morrison, W. L. (2005). Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart, 91, 1173-1175.
95. Xu, J., He, L., Ahmed, S. H., Chen, S. W., Goldberg,M. P., Beckman, J. S., et al. (2000). Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke, 31, 1744-1751.
96. Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., et al. (1995). Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. Journal of Biological Chemistry, 270, 11463-11471.
97. Young, J. D., & McGwire, B. S. (2005). Infliximab and reactivation of cerebral toxoplasmosis. The New England Journal of Medicine, 353, 1530-1531.
98. Zhang, W., Smith, C., Howlett, C., & Stanimirovic, D. (2000). Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta. Journal of Cerebral Blood Flow and Metabolism, 20, 967-978.